Cadence Bank NA’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,533
| Closed | -$3.42M | – | 130 |
|
|
2022
Q2 | $3.42M | Sell |
10,533
-147
| -1% | -$44.1K | 1.11% | 25 |
|
|
2022
Q1 | $3.06M | Sell |
10,680
-10
| -0.1% | -$2.57K | 0.85% | 37 |
|
|
2021
Q4 | $2.95M | Buy |
10,690
+58
| +0.5% | +$14.7K | 0.8% | 38 |
|
|
2021
Q3 | $2.46M | Sell |
10,632
-335
| -3% | -$82.7K | 0.73% | 41 |
|
|
2021
Q2 | $2.52M | Sell |
10,967
-231
| -2% | -$46.4K | 0.75% | 40 |
|
|
2021
Q1 | $2.09M | Sell |
11,198
-132
| -1% | -$25.8K | 0.66% | 45 |
|
|
2020
Q4 | $1.91M | Buy |
11,330
+13
| +0.1% | +$1.94K | 0.67% | 43 |
|
|
2020
Q3 | $1.68M | Buy |
11,317
+123
| +1% | +$19K | 0.65% | 41 |
|
|
2020
Q2 | $1.84M | Buy |
11,194
+213
| +2% | +$32.7K | 0.78% | 36 |
|
|
2020
Q1 | $1.52M | Sell |
10,981
-6,384
| -37% | -$877K | 0.78% | 34 |
|
|
2019
Q4 | $2.28M | Sell |
17,365
-77
| -0.4% | -$8.93K | 0.84% | 34 |
|
|
2019
Q3 | $1.95M | Buy |
17,442
+601
| +4% | +$66.9K | 0.76% | 39 |
|
|
2019
Q2 | $1.87M | Sell |
16,841
-1,876
| -10% | -$221K | 0.73% | 39 |
|
|
2019
Q1 | $2.43M | Sell |
18,717
-1,304
| -7% | -$159K | 0.95% | 28 |
|
|
2018
Q4 | $2.32M | Buy |
20,021
+437
| +2% | +$48.8K | 1.04% | 23 |
|
|
2018
Q3 | $2.1M | Sell |
19,584
-3,954
| -17% | -$395K | 0.8% | 36 |
|
|
2018
Q2 | $2.01M | Sell |
23,538
-610
| -3% | -$50.1K | 0.82% | 33 |
|
|
2018
Q1 | $1.87M | Sell |
24,148
-325
| -1% | -$26.2K | 0.74% | 44 |
|
|
2017
Q4 | $2.07M | Buy |
24,473
+1,289
| +6% | +$110K | 0.76% | 41 |
|
|
2017
Q3 | $1.98M | Sell |
23,184
-536
| -2% | -$44K | 0.75% | 41 |
|
|
2017
Q2 | $1.95M | Buy |
23,720
+95
| +0.4% | +$7.75K | 0.89% | 35 |
|
|
2017
Q1 | $1.99M | Buy |
23,625
+574
| +2% | +$46K | 0.92% | 30 |
|
|
2016
Q4 | $1.7M | Buy |
23,051
+1,186
| +5% | +$88.3K | 0.79% | 39 |
|
|
2016
Q3 | $1.75M | Buy |
21,865
+584
| +3% | +$46.7K | 0.79% | 37 |
|
|
2016
Q2 | $1.68M | Buy |
21,281
+4,740
| +29% | +$357K | 0.82% | 32 |
|
|
2016
Q1 | $1.19M | Buy |
16,541
+633
| +4% | +$47.9K | 0.61% | 47 |
|
|
2015
Q4 | $1.34M | Buy |
15,908
+1,091
| +7% | +$90.5K | 0.72% | 31 |
|
|
2015
Q3 | $1.24M | Buy |
14,817
+8,594
| +138% | +$726K | 0.72% | 33 |
|
|
2015
Q2 | $520K | Buy |
6,223
+352
| +6% | +$26.8K | 0.34% | 56 |
|
|
2015
Q1 | $426K | Sell |
5,871
-300
| -5% | -$21.4K | 0.24% | 88 |
|
|
2014
Q4 | $425K | Buy |
6,171
+58
| +0.9% | +$3.92K | 0.23% | 90 |
|
|
2014
Q3 | $397K | Buy |
6,113
+91
| +2% | +$5.76K | 0.21% | 90 |
|
|
2014
Q2 | $374K | Sell |
6,022
-313
| -5% | -$18.7K | 0.2% | 94 |
|
|
2014
Q1 | $373K | Sell |
6,335
-1,417
| -18% | -$79.1K | 0.22% | 87 |
|
|
2013
Q4 | $396K | Buy |
7,752
+538
| +7% | +$26.9K | 0.21% | 85 |
|
|
2013
Q3 | $363K | Sell |
7,214
-21
| -0.3% | -$1.1K | 0.22% | 89 |
|
|
2013
Q2 | $355K | Buy |
+7,235
| New | +$394K | 0.19% | 93 |
|
Other funds holding LLY
Cadence Bank NA's LLY Position: Q3 2022 in Review
Cadence Bank NA sold out of Eli Lilly (LLY) in Q3 2022, closing a stake of 10,533 shares — an estimated $3.42M sold.
Cadence Bank NA first reported a position in LLY in Q2 2013 and held it in 37 quarters. The position peaked at $3.42M in Q2 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- Cadence Bank NA reported no remaining Eli Lilly position as of Q3 2022 after selling out during the quarter.
- Cadence Bank NA sold 10,533 Eli Lilly shares in Q3 2022, an estimated $3.42M.
- Cadence Bank NA first reported a position in Eli Lilly in Q2 2013 and held it in 37 quarters.
- Cadence Bank NA's Eli Lilly position peaked at $3.42M in Q2 2022.
- 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on Cadence Bank NA's 13F filing for Q3 2022, filed 27 Oct 2022.